| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |